Practical management of lipid disorders.
Hyperlipidemia is a common disease that leads to considerable morbidity and mortality. It is a major risk factor for the development of atherosclerosis. Hyperlipidemia is often undertreated by medical providers. Several large, randomized trials have established the benefit of aggressive management of hyperlipidemia. Effective treatment requires a multidisciplinary approach. There are many cholesterol-lowering medications on the market. The HMG-coA-reductase inhibitors are the most efficacious and are well tolerated.
Skillings
J
J
Division of Cardiology, Baltimore VA Medical Center, Maryland 21201, USA.
D001161:Arteriosclerosis / Q000209:etiology; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008019:Life Style; D010348:Patient Care Team; D018579:Patient Selection; D011320:Primary Health Care / Q000379:methods*; D016896:Treatment Outcome
D000960:Hypolipidemic Agents